Severe persistent asthma represents the most clinically challenging, therapeutically demanding, and prognostically serious end of the asthma severity spectrum, affecting approximately five to ten percent of the asthma population but accounting for more than fifty percent of asthma-related healthcare costs, hospitalizations, and mortality. Despite these disproportionate clinical and economic impacts, severe asthma remains one of […]
